In this week’s View, Dr. Eagle looks at contemporary outcomes and trends for the transseptal mitral valve-in-valve procedure using balloon-expandable transcatheter valves. He then explores complete vs ...

Beta-blocker use did not result in a lower incidence of composite death or new AMI, all-cause death, AMI, or heart failure ...

In this special edition of Eagle’s Eye View, Dr. Eagle looks at the most important trials presented at the recent AHA scientific sessions: 1) BROAD, exploring more intensive blood pressure control; 2) ...

New science presented at AHA 2024 and simultaneously published in JACC: Advances provide insights on emerging topics such as the use of artificial intelligence (AI)-enabled left atrial (LA) volumetry ...

The ACC recognizes more than 2,000 hospitals and facilities participating in NCDR registries and ACC Accreditation Services in the ACC insert of the 2025 U.S. News and World Report “Best Hospitals” ...

Cardiovascular clinicians will see several new CPT® and HCPCS codes starting Jan. 1, 2025. The ACC Advocacy team has prepared the following overview detailing telehealth coding updates, new Category ...

Nonsustained ventricular tachycardia (NSVT) is roughly as common in athletes as in the general population, and is more frequently associated with structural abnormalities in those with higher burden ...

In this week’s View, Dr. Eagle looks at exercise training in patients with hypertrophic cardiomyopathy (HCM). He then reviews the diagnosis and management of Kawasaki Disease. Finally, Dr. Eagle ...

Disparities in health care disproportionally impact under-resourced and minority communities resulting in excess mortality and morbidity. Decreasing and eliminating these disparities will improve ...

Previously used pacemakers reconditioned with an U.S. Food and Drug Administration-approved protocol worked as well as new devices at 90 days, based on findings from the My Heart Your Heart (MHYH) ...

Edoxaban was comparable to warfarin in preventing stroke or systemic embolism and intracardiac thrombus in patients with non-valvular atrial fibrillation (AFib) within three months after bioprosthetic ...

Norland K, Schaid DJ, Naderian M, Na J, Kullo IJ.